Keywords
Number of items: 2.
Data from: Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ Lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial. (2015)
Landay, Alan; Reither, Klaus; Katsoulis, Lynn; Beattie, Trevor; Gardiner, Nicolene; Lenz, Nicole; Said, Khadija; Mfinanga, Elirehema; Pohl, Christian; Fielding, Katherine L.; Jeffery, Hannah; Kagina, Benjamin M.; Hughes, Elisabeth J.; Scriba, Thomas J.; Hanekom, Willem A.; Hoff, Søren T.; Bang, Peter; Kromann, Ingrid; Daubenberger, Claudia; Andersen, Peter; Churchyard, Gavin J.
tomsumner/Timing_of_vaccination. (2025)
Sumner, Tom